Literature DB >> 10654591

Sphinganine/sphingosine ratio in plasma and urine as a possible biomarker for fumonisin exposure in humans in rural areas of Africa.

L van der Westhuizen1, N L Brown, W F Marasas, S Swanevelder, G S Shephard.   

Abstract

This study was conducted in the Transkei region of the Eastern Cape and KwaZulu-Natal province, South Africa and in the Bomet district, western Kenya. The sphinganine (Sa)/sphingosine (So) ratios in the plasma and urine of male and female volunteers consuming a staple diet of home-grown maize in Transkei, were 0.34 +/- 0.36 (mean +/- standard deviation) (n = 154) and 0.41 +/- 0.72 (n = 153), respectively and in plasma samples from KwaZulu-Natal it was 0.44 +/- 0.23 (n = 26). In Kenya, the ratios in plasma and urine were 0.28 +/- 0.07 (n = 29) and 0.34 +/- 0.20 (n = 27), respectively. Mean total fumonisin level in home-grown maize, randomly collected in Transkei from the same region where the human volunteers lived, was 580 ng/g (n = 40), as compared to the KwaZulu-Natal province, where no fumonisin (n = 17) were detected (< 10 ng/g) in the home-grown maize. In Kenya, only one of seven samples was contaminated with 60 ng/g fumonisins. No significant differences were found in the Sa/So ratios between males and females within the regions nor between the different regions (P > 0.05). It is possible that the ratio is not sensitive enough to act as a biomarker for fumonisin exposure in humans at these levels of contamination in maize. This is the first report on Sa/So ratios determined in rural populations in Africa consuming home-grown maize as their staple diet.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10654591     DOI: 10.1016/s0278-6915(99)00113-1

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  5 in total

1.  Mycotoxins and human disease: a largely ignored global health issue.

Authors:  Christopher P Wild; Yun Yun Gong
Journal:  Carcinogenesis       Date:  2009-10-29       Impact factor: 4.944

2.  Validation of fumonisin biomarkers in F344 rats.

Authors:  Qingsong Cai; Lili Tang; Jia-Sheng Wang
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-16       Impact factor: 4.219

3.  Discovery and occurrence of the fumonisins: a historical perspective.

Authors:  W F Marasas
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

Review 4.  Human Biomonitoring of Selected Hazardous Compounds in Portugal: Part II-Lessons Learned on Mycotoxins.

Authors:  Angelina Pena; Sofia Duarte; André M P T Pereira; Liliana J G Silva; Célia S M Laranjeiro; Marta Oliveira; Celeste Lino; Simone Morais
Journal:  Molecules       Date:  2021-12-27       Impact factor: 4.411

5.  Efficacy of Fumonisin Esterase in Piglets as Animal Model for Fumonisin Detoxification in Humans: Pilot Study Comparing Intraoral to Intragastric Administration.

Authors:  Kaat Neckermann; Gunther Antonissen; Barbara Doupovec; Dian Schatzmayr; James Gathumbi; Véronique Delcenserie; Silvio Uhlig; Siska Croubels
Journal:  Toxins (Basel)       Date:  2022-02-11       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.